| Sub Cat | Immunogen | Isotype | Application | Affinity | |
|---|---|---|---|---|---|
| V3S-1022-YC3010 | 6×His tagged recombinant human GDF15 (His-rhGDF15) | IgG1 kappa | WB; ELISA | 0.21 nM (mFc-rhGDF15) | |
| V3S-1022-YC3011 | 6×His tagged recombinant human GDF15 (His-rhGDF15) | IgG1 kappa | WB; ELISA | 0.22 nM (mFc-rhGDF15) | |
| V3S-1022-YC3012 | 6×His tagged recombinant human GDF15 (His-rhGDF15) | IgG1 kappa | WB; ELISA | 0.19 nM (mFc-rhGDF15) | |
| V3S-0622-YC188 | Recombinant MIC-1 protein was converted to cDNA | IgG | ELISA; Inhib | ||
| V3S-0622-YC189 | Recombinant MIC-1 protein was converted to cDNA | IgG | ELISA; Inhib |
| Description | These monoclonal antibodies bind human GDF15. Some of these clones can block angiogenic function of MIC-1. The antibodies can be used for research of GDF15-related diseases (e.g. Cachexia). |
| Clonality | Monoclonal |
| Host Species | Mouse |
| Target Species | Human |
| Immunogen | Recombinant GDF15 protein |
| Isotype | Mouse IgG |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and/or SEC-HPLC |
| Endotoxin | <1 EU/mg, determined by LAL method |
| Purification | Protein A affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C. |
| Application | ELISA, Inhib, WB |
| Application Notes | The antibodies are recommended for ELISA, Western blot or Inhibition assay. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
